<Record>
<Term>Fatty Acid Synthesis Inhibitors</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Antilipemic Agents</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Molecular Mechanisms of Pharmacological Action/Antimetabolites/Antilipemic Agents/Fatty Acid Synthesis Inhibitors</ClassificationPath>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Fatty Acid Synthesis Inhibitors</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Antilipemic Agents</BroaderTerm>
<BroaderTerm>Antimetabolites</BroaderTerm>
<BroaderTerm>Molecular Mechanisms of Pharmacological Action</BroaderTerm>
<Synonym>Fatty Acid Synthesis Inhibitors</Synonym>
<Description>Compounds that interfere with FATTY ACID SYNTHASE resulting in a reduction of FATTY ACIDS. This is a target mechanism in humans of some ANTINEOPLASTIC AGENTS and ANTI-OBESITY AGENTS and of  some ANTI-INFECTIVE AGENTS which interfere with CELL WALL and CELL MEMBRANE formation.</Description>
<Source>MeSH</Source>
</Record>
